Cargando…
The Orally Available, Synthetic Ether Lipid Edelfosine Inhibits T Cell Proliferation and Induces a Type I Interferon Response
The drug edelfosine is a synthetic analog of 2-lysophosphatidylcholine. Edelfosine is incorporated by highly proliferating cells, e.g. activated immune cells. It acts on cellular membranes by selectively aggregating the cell death receptor Fas in membrane rafts and interference with phosphatidylchol...
Autores principales: | Abramowski, Pierre, Otto, Benjamin, Martin, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3965404/ https://www.ncbi.nlm.nih.gov/pubmed/24667731 http://dx.doi.org/10.1371/journal.pone.0091970 |
Ejemplares similares
-
Involvement of lipid rafts in the localization and dysfunction effect of the antitumor ether phospholipid edelfosine in mitochondria
por: Mollinedo, F, et al.
Publicado: (2011) -
In Vitro and In Vivo Efficacy of Ether Lipid Edelfosine against Leishmania spp. and SbV-Resistant Parasites
por: Varela-M, Rubén E., et al.
Publicado: (2012) -
Mitochondrial Targeting Involving Cholesterol-Rich Lipid Rafts in the Mechanism of Action of the Antitumor Ether Lipid and Alkylphospholipid Analog Edelfosine
por: Mollinedo, Faustino, et al.
Publicado: (2021) -
Direct Endoplasmic Reticulum Targeting by the Selective Alkylphospholipid Analog and Antitumor Ether Lipid Edelfosine as a Therapeutic Approach in Pancreatic Cancer
por: Mollinedo, Faustino, et al.
Publicado: (2021) -
Mitochondria and lipid raft-located F(O)F(1)-ATP synthase as major therapeutic targets in the antileishmanial and anticancer activities of ether lipid edelfosine
por: Villa-Pulgarín, Janny A., et al.
Publicado: (2017)